As a company, Vertex says, “We strike at the core of serious diseases to change people’s lives. Bringing together the ...

On March 7, 2025, Vertex Pharmaceuticals announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its ...